Catalyst Wire Dossier Catalyst Wire Dossier

Rebiject Mini

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rebiject Mini, covering 2013-08-06 to 2013-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects [Phase 3]

See pricing